Research institut

Namur Institute of Language, Text and Transmediality

Bringing together linguists and literary scholars, UNamur's Institute of Language, Text and Transmediality provides a platform for interdisciplinary diachronic and synchronic research into the multiple ways in which different types of verbal and multimodal communicative practices manifest themselves in, give shape to, are regulated by and reflect culture and society.

See content
Research institut

Namur Research Institute for Life Sciences

NARILIS seeks to stimulate two-way interactions between basic researchers and physicians, and to build bridges between the laboratory and the patient's bedside. NARILIS therefore aims to facilitate the translation of basic research findings into clinical applications. Its mission is to promote multidisciplinary research in order to improve human and animal health and quality of life.

See content
Article

QUALIblood, a spin-off for the medicine of tomorrow

One of the major concerns with the disease caused by Covid-19 is its severe course, which causes many problems that can lead to hospital overload. Early detection of whether or not a person is at risk of developing a severe form of the disease is therefore crucial to optimise patient care and hospital resource management. This is one of the objectives of the study carried out by QUALIblood, a UNamur spin-off, in collaboration with the Department of Pharmacy and many other industrial and hospital partners. Exploration of a cutting-edge technology at the service of health.
See content
Article

"School and Deafness" by M. Ghesquière and L. Meurant wins an award

On 30 November 2022, Magaly Ghesquière and Laurence Meurant (UNamur), co-authors of the book "School and Deafness” (in French “Ecole et Surdité - Une expérience d'enseignement bilingue et inclusif", received the prize for the best book for Teaching and Continuing Education from the Parliament of the Wallonia-Brussels Federation. This is another fine award that complements the recent release of the first bilingual sign language-French contextual dictionary searchable in sign language.
See content
Article

Yves Poumay, researcher on skin pathologies

As the largest and heaviest organ in the human body, the skin is the focus of Professor Yves Poumay's research. For nearly 30 years, within the Cells and Tissues laboratory (LabCeTi), he has been developing in vitro epidermal models that reproduce skin pathologies to better understand and treat them. A pioneering approach that offers alternatives to animal experimentation! On the eve of an international congress devoted to dermatology research organised at UNamur (see below), he talks about the importance of melanoma screening and details the latest advances in dermatology made in his laboratory.
See content
Article

Lysosome: from protein transport to bone remodelling

The lysosome, a small intracellular organelle, is often represented as the stomach of the cell due to its acidity and the presence of numerous digestive enzymes within it. Its role? The degradation of numerous molecules and their recycling to build new molecules and fuel energy production in the cells. Since 2003, Marielle Boonen has been particularly interested in the lysosome. Together with researchers from UNamur, she has highlighted the role of a lysosomal enzyme called HYAL1 in the bone remodelling process.
See content
Article

A new collaboration with Benin

In January 2023, Professor Romain Houssa of UNamur led a Belgian delegation to formulate a new ARES Institutional Support (IS) programme at the University of Abomey-Calavi (UAC) in Benin. This multidisciplinary research and innovation support programme aims to strengthen scientific collaboration between FWB researchers and Benin as well as other countries in the West African region, notably Togo, Niger and Burkina Faso.
See content
Article

World first: a French-Sign language dictionary

A bilingual French-sign language dictionary (LSFB), which can be queried in both languages, thanks to cutting-edge technology (facial recognition) and access to a vast database compiling more than 4,500 signs, words and expressions.
See content
Article

Karel Mertens, guest of the 2023 International Francqui Chair in macroeconomics

Karel Mertens is a renowned researcher who has done outstanding work in the field of macroeconomics. He is staying in Belgium for three months to take part in the activities of the International Francqui Chair organized by the Department of Economics of the UNamur, in collaboration with KU Leuven, UAntwerp, Ghent University, UCLouvain, and the National Bank of Belgium. Interview.
See content
Article

An AstraZeneca-FNRS-FWO Foundation award for Charlotte Beaudart

On 13 December 2023, Charlotte Beaudart, a new academic at the University of Namur Faculty of Medicine, will be awarded a prize at the annual ceremony for Belgian scientific research in support of her innovative research on the subject of ageing.
See content
Article

Understanding the history of violence against women in Senegal: research wins ARES "Gender and Health" award

Angélique Aristondo, a C2W post-doctoral fellow at UNamur, has distinguished herself by winning the second 2023 Gender and Health Research Award from the ARES Women and Science Committee. Her research project focuses on violence against women in Senegal.
See content
Event

Public thesis defense - Pauline TRICQUET

The Elongator complex is involved in the addition of 5'-carboxylmethyluridine (cm5U)-derived modifications to transfer RNAs (tRNAs), thereby influencing the translation of certain messenger RNAs (mRNAs) and helping to maintain the integrity of the proteome. This complex is involved in a variety of biological processes, and is of particular importance in oncology. The identification of chemical inhibitors of Elongator is of significant interest in both basic and pharmaceutical research.Through a yeast screen, this work reveals a potential new role for Elongator and identifies a chemical inhibitor of the complex. This compound presents itself as an interesting candidate as a pharmacological inhibitor, opening up new perspectives for the search for anti-cancer therapies.
See content